A revolutionary therapeutic approach for psoriasis: bispecific biological agents

被引：66

作者：

Torres, T. ^{[1
,2
]}

Romanelli, M. ^{[3
]}

Chiricozzi, A. ^{[3
]}

机构：

[1] Univ Porto, Ctr Hosp Porto, Dept Dermatol, Rua Campo Alegre 823, P-4100 Oporto, Portugal

[2] Univ Porto, Inst Ciencias Biomed Abel Salazar, Rua Campo Alegre 823, P-4100 Oporto, Portugal

[3] Univ Pisa, Dept Dermatol, Via Roma 67, I-56126 Pisa, Italy

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2016年 / 25卷 / 07期

关键词：

NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; ETANERCEPT; RESPONSES; INTERLEUKIN-17; INHIBITION; ANTIBODY;

D O I：

10.1080/13543784.2016.1187130

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：751 / 754

页数：4

共 22 条

[1]

Therapeutic antibodies for autoimmunity and inflammation [J].

Chan, Andrew C. ;

Carter, Paul J. .

NATURE REVIEWS IMMUNOLOGY, 2010, 10 (05) :301-316

[2]

A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast [J].

Chiricozzi, Andrea ;

Caposiena, Dante ;

Garofalo, Virginia ;

Cannizzaro, Maria Vittoria ;

Chimenti, Sergio ;

Saraceno, Rosita .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (03) :237-249

[3]

IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model [J].

Chiricozzi, Andrea ;

Nograles, Kristine E. ;

Johnson-Huang, Leanne M. ;

Fuentes-Duculan, Judilyn ;

Cardinale, Irma ;

Bonifacio, Kathleen M. ;

Gulati, Nicholas ;

Mitsui, Hiroshi ;

Guttman-Yassky, Emma ;

Suarez-Farinas, Mayte ;

Krueger, James G. .

PLOS ONE, 2014, 9 (02)

[4]

Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis [J].

Chiricozzi, Andrea ;

Guttman-Yassky, Emma ;

Suarez-Farinas, Mayte ;

Nograles, Kristine E. ;

Tian, Suyan ;

Cardinale, Irma ;

Chimenti, Sergio ;

Krueger, James G. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (03) :677-687

[5]

Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis Development and Characterization of a Novel Bispecific Antibody [J].

Fischer, Jens A. A. ;

Hueber, Axel J. ;

Wilson, Stacy ;

Galm, Margarete ;

Baum, Wolfgang ;

Kitson, Christopher ;

Auer, Johannes ;

Lorenz, Stefan H. ;

Moelleken, Joerg ;

Bader, Martin ;

Tissot, Alain C. ;

Tan, Seng-Lai ;

Seeber, Stefan ;

Schett, Georg .

ARTHRITIS & RHEUMATOLOGY, 2015, 67 (01) :51-62

[6]

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate [J].

Genovese, MC ;

Cohen, S ;

Moreland, L ;

Lium, D ;

Robbins, S ;

Newmark, R ;

Bekker, P .

ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1412-1419

[7]

Glatt S, 2016, 74 ANN M AM AC DERM

[8]

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials [J].

Griffiths, Christopher E. M. ;

Reich, Kristian ;

Lebwohl, Mark ;

van de Kerkhof, Peter ;

Paul, Carle ;

Menter, Alan ;

Cameron, Gregory S. ;

Erickson, Janelle ;

Zhang, Lu ;

Secrest, Roberta J. ;

Ball, Susan ;

Braun, Daniel K. ;

Osuntokun, Olawale O. ;

Heffernan, Michael P. ;

Nickoloff, Brian J. ;

Papp, Kim .

LANCET, 2015, 386 (9993) :541-551

[9]

The effect of adalimumab on key drivers in the pathogenesis of psoriasis [J].

Hendriks, A. G. M. ;

van der Velden, H. M. J. ;

Wolberink, E. A. W. ;

Seyger, M. M. B. ;

Schalkwijk, J. ;

Zeeuwen, P. L. J. M. ;

de Jong, E. M. G. J. ;

Pasch, M. C. ;

van Erp, P. E. J. ;

van de Kerkhof, P. C. M. .

BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (03) :571-580

[10]

Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling [J].

Johnston, A. ;

Guzman, A. M. ;

Swindell, W. R. ;

Wang, F. ;

Kang, S. ;

Gudjonsson, J. E. .

BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) :97-107

← 1 2 3 →